24th Apr 2017 16:52
The following amendment has been made to the Director/PDMR Shareholding announcement released on 19 April 2017 at 13:27 (BST) under RNS No 7391C.
Removal of the text which incorrectly reported that 13.866 Ordinary Shares had been acquired following the re-investment of dividends paid to shareholders on 13 April 2017 on released shares from the Company's 2009 Deferred Annual Bonus Plan on a post-tax basis - Matching Award.
All other details remain unchanged.
The full amended text is shown below.
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||
a) | Name | Ms C Thomas | ||||
b) | Position/status | SVP, HR | ||||
c) | Initial notification/ amendment | Amendment | ||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | GlaxoSmithKline plc | ||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
| ||||
b) | Nature of the transaction | Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on released shares from the Company's 2009 Deferred Annual Bonus Plan on a post-tax basis - Co-investment shares. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
Aggregated volume Price | n/a (single transaction)
| ||||
e) | Date of the transaction | 2017-04-18 | ||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||
Related Shares:
Glaxosmithkline